Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company revolutionizing care for patients with challenging respiratory and vascular diseases, announced today the company will present three ...

For children with established AD and food allergies, early systemic therapy, including dupilumab and JAK inhibitors, may interrupt progression along the atopic march, with data supporting both ...

While Silicon Valley pours billions into longevity tech and concierge medicine for the ultra-wealthy, OMNY Health is building something far more radical: a data infrastructure that can actually ...

Health tech startup Dandelion Health launched a clinical artificial intelligence marketplace that merges third-party algorithms and Dandelion's data platform and model validation capabilities to ...

Application developers and solution partners often need to process healthcare data outside of the electronic medical record (EMR) system. EMRs are primarily designed to directly support individual ...

Jasper Therapeutics, Inc. announced that it is presenting updated clinical data from its Phase 1b/2a BEACON study on briquilimab, an antibody therapy targeting c-Kit to treat mast cell-driven diseases ...

Payer-provider clinical data exchange plays a critical role in payer operations, helping streamline workflows and improve patient care. Traditionally, this exchange ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. With more than a third of hospitals experiencing negative operating margins, healthcare ...

CRISPR Therapeutics reports promising Phase 1 clinical data for CTX310™, with significant triglyceride and LDL reductions, and updates on other programs. CRISPR Therapeutics announced promising new ...

This article is part of our series on clinical data considerations. Read How to Approach Fundraising and Investor Relations. When it comes to disclosing clinical trial data in the biotechnology arena, ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...